Winner Medical Co., Ltd. (300888.SZ)
CNY 43.5
(-2.33%)
CNY 43.5
(-2.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17.11 Billion CNY | -6.17% |
| 2022 | 18.23 Billion CNY | 37.47% |
| 2021 | 13.26 Billion CNY | 2.03% |
| 2020 | 13 Billion CNY | 186.93% |
| 2019 | 4.53 Billion CNY | 14.48% |
| 2018 | 3.95 Billion CNY | 16.75% |
| 2017 | 3.39 Billion CNY | 47.36% |
| 2016 | 2.3 Billion CNY | 36.86% |
| 2015 | 1.68 Billion CNY | 11.58% |
| 2014 | 1.5 Billion CNY | 31.61% |
| 2013 | 1.14 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 16.77 Billion CNY | 1.72% |
| 2024 Q3 | 17.84 Billion CNY | 6.35% |
| 2024 Q1 | 16.49 Billion CNY | -3.61% |
| 2023 Q3 | 19.05 Billion CNY | 10.24% |
| 2023 FY | 17.11 Billion CNY | -6.17% |
| 2023 Q4 | 17.11 Billion CNY | -10.21% |
| 2023 Q1 | 18.02 Billion CNY | -1.14% |
| 2023 Q2 | 17.28 Billion CNY | -4.11% |
| 2022 Q3 | 16.49 Billion CNY | 6.29% |
| 2022 Q1 | 13.62 Billion CNY | 2.72% |
| 2022 FY | 18.23 Billion CNY | 37.47% |
| 2022 Q4 | 18.23 Billion CNY | 10.54% |
| 2022 Q2 | 15.52 Billion CNY | 13.91% |
| 2021 Q4 | 13.26 Billion CNY | 0.13% |
| 2021 Q2 | 13.11 Billion CNY | -3.23% |
| 2021 Q1 | 13.55 Billion CNY | 4.21% |
| 2021 FY | 13.26 Billion CNY | 2.03% |
| 2021 Q3 | 13.24 Billion CNY | 1.04% |
| 2020 Q3 | 12.57 Billion CNY | 68.34% |
| 2020 FY | 13 Billion CNY | 186.93% |
| 2020 Q2 | 7.46 Billion CNY | 0.0% |
| 2020 Q4 | 13 Billion CNY | 3.43% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q1 | 4.01 Billion CNY | 0.0% |
| 2019 FY | 4.53 Billion CNY | 14.48% |
| 2019 Q4 | 4.53 Billion CNY | 0.0% |
| 2019 Q2 | 4.01 Billion CNY | 0.0% |
| 2018 FY | 3.95 Billion CNY | 16.75% |
| 2017 FY | 3.39 Billion CNY | 47.36% |
| 2016 FY | 2.3 Billion CNY | 36.86% |
| 2015 FY | 1.68 Billion CNY | 11.58% |
| 2014 FY | 1.5 Billion CNY | 31.61% |
| 2013 FY | 1.14 Billion CNY | 0.0% |